Suppr超能文献

美国新诊断 2 型糖尿病成年人并发症 30 年趋势。

Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes.

机构信息

Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

出版信息

Diabetes Care. 2021 Mar;44(3):699-706. doi: 10.2337/dc20-2304. Epub 2021 Jan 8.

Abstract

OBJECTIVE

To assess the prevalence of and trends in complications among U.S. adults with newly diagnosed diabetes.

RESEARCH DESIGN AND METHODS

We included 1,486 nonpregnant adults (aged ≥20 years) with newly diagnosed diabetes (diagnosed within the past 2 years) from the 1988-1994 and 1999-2018 National Health and Nutrition Examination Survey. We estimated trends in albuminuria (albumin-to-creatinine ratio ≥30 mg/g), reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m), retinopathy (any retinal microaneurysms or blot hemorrhages), and self-reported cardiovascular disease (history of congestive heart failure, heart attack, or stroke).

RESULTS

From 1988-1994 to 2011-2018, there was a significant decrease in the prevalence of albuminuria (38.9 to 18.7%, for trend <0.001) but no change in the prevalence of reduced eGFR (7.5 to 9.9%, for trend = 0.30), retinopathy (1988-1994 to 1999-2008 only; 13.2 to 12.1%, for trend = 0.86), or self-reported cardiovascular disease (19.0 to 16.5%, for trend = 0.64). There were improvements in glycemic, blood pressure, and lipid control in the population, and these partially explained the decline in albuminuria. Complications were more common at the time of diabetes diagnosis for adults who were older, lower income, less educated, and obese.

CONCLUSIONS

Over the past three decades, there have been encouraging reductions in albuminuria and risk factor control in adults with newly diagnosed diabetes. However, the overall burden of complications around the time of the diagnosis remains high.

摘要

目的

评估美国新诊断糖尿病患者的并发症患病率及变化趋势。

研究设计和方法

我们纳入了 1988-1994 年和 1999-2018 年全国健康与营养调查中 1486 名年龄≥20 岁的无妊娠史新诊断糖尿病患者(在过去 2 年内确诊)。我们评估了白蛋白尿(白蛋白/肌酐比值≥30mg/g)、估算肾小球滤过率(eGFR<60mL/min/1.73m2)降低、视网膜病变(任何视网膜微动脉瘤或出血斑)和心血管疾病自我报告(充血性心力衰竭、心脏病发作或中风病史)的变化趋势。

结果

1988-1994 年至 2011-2018 年,白蛋白尿的患病率显著下降(从 38.9%降至 18.7%,趋势<0.001),但 eGFR 降低的患病率无变化(从 7.5%降至 9.9%,趋势=0.30),视网膜病变(仅在 1988-1994 年至 1999-2008 年)、心血管疾病自我报告(从 19.0%降至 16.5%,趋势=0.64)患病率也无变化。人群的血糖、血压和血脂控制有所改善,这部分解释了白蛋白尿的下降。在诊断为糖尿病时,年龄较大、收入较低、受教育程度较低和肥胖的成年人并发症更为常见。

结论

在过去的三十年中,新诊断糖尿病患者的白蛋白尿和危险因素控制有了令人鼓舞的改善。然而,在诊断时并发症的总体负担仍然很高。

相似文献

4
The kidney and cardiovascular outcome trials.肾脏和心血管结局试验。
J Diabetes. 2018 Feb;10(2):88-89. doi: 10.1111/1753-0407.12616.

引用本文的文献

本文引用的文献

1
10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S111-S134. doi: 10.2337/dc20-S010.
2
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76. doi: 10.2337/dc20-S006.
3
New directions in incidence and prevalence of diagnosed diabetes in the USA.美国诊断糖尿病发病率和患病率的新方向。
BMJ Open Diabetes Res Care. 2019 May 28;7(1):e000657. doi: 10.1136/bmjdrc-2019-000657. eCollection 2019.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验